Personalized Medical Oncology at GCCC
Medical oncology is the backbone of cancer treatment for many patients — whether used as primary therapy, adjuvant (post-surgery) treatment, neoadjuvant (pre-surgery) treatment, or palliative care. At GCCC, our medical oncologists develop personalized treatment plans based on the latest clinical evidence, molecular profiling, and each patient's unique clinical situation.
Key advantage: We integrate molecular and genetic testing into treatment planning — identifying actionable mutations that can be targeted with specific drugs, which often results in better efficacy and fewer side effects than traditional chemotherapy alone.
Treatment Modalities
Chemotherapy
Our chemotherapy unit provides a full range of cytotoxic chemotherapy regimens following NCCN and ESMO guidelines. Treatment is delivered in a comfortable infusion center with individual treatment bays, continuous monitoring, and experienced oncology nursing staff. We manage all common chemotherapy toxicities proactively with modern supportive care protocols.
Targeted Therapy
For patients whose tumors harbor specific genetic mutations, targeted therapy offers a more precise approach. We routinely test for and treat with targeted agents for:
- EGFR, ALK, ROS1, KRAS, BRAF — non-small cell lung cancer
- HER2 — breast cancer and gastric cancer
- BRAF, MSI-H — colorectal cancer
- IDH1, FGFR2 — cholangiocarcinoma
- KIT, PDGFRA — gastrointestinal stromal tumors (GIST)
- And many other actionable targets across tumor types
Immunotherapy
Immune checkpoint inhibitors (anti-PD-1, anti-PD-L1, anti-CTLA-4) have revolutionized cancer treatment in recent years. Our medical oncologists are experienced in patient selection, administration, and management of immune-related adverse events. Immunotherapy is used for:
- Non-small cell lung cancer
- Melanoma
- Hodgkin and non-Hodgkin lymphoma
- Head and neck squamous cell carcinoma
- MSI-H/dMMR solid tumors (tumor-agnostic indication)
- Hepatocellular carcinoma
- Gastric and esophageal cancer
- And expanding indications per latest clinical evidence
Hormonal Therapy
For hormone-sensitive cancers (breast, prostate), we offer comprehensive endocrine therapy options including aromatase inhibitors, selective estrogen receptor modulators (SERMs), GnRH agonists, and androgen receptor signaling inhibitors, always coordinated with other treatment modalities.
Supportive Care
Managing cancer treatment side effects is an integral part of our medical oncology service. Our supportive care program includes:
- Proactive antiemetic protocols for chemotherapy-induced nausea
- Growth factor support (G-CSF, ESA) to maintain treatment schedules
- Pain management consultation
- Nutritional counseling and support
- Psychological support services
- Integrative therapies (acupuncture, TCM) to manage treatment-related symptoms